Cost Sharing in Insurance Coverage for Precision Medicine

Mark V. Pauly

NBER Working Paper No. 24095
Issued in December 2017
NBER Program(s):Health Economics

This paper describes current pattern of insurance coverage for precision medicines and, especially, companion diagnostics and explores what coverage would improve efficiency. We find that currently coverage is common for tests and treatments with clinical acceptance used at high volumes but is haphazard across both private insurers and Medicare for precision medicines in general. Analysis of the case of homogenous patient preferences finds that discovery and use of the test that converts an ordinary drug into a precision drug can either increase or decrease total spending, and might call for full or no coverage of test and treatments. Heterogeneity in marginal benefits from testing and treatment can call for partial coverage. Finally, varying threshold levels for diagnostic test results can lead to a demand curve to test and treatment that calls for partial cost sharing. Numerical examples and case studies of several test-treatment combinations illustrate these points.

You may purchase this paper on-line in .pdf format from ($5) for electronic delivery.

Access to NBER Papers

You are eligible for a free download if you are a subscriber, a corporate associate of the NBER, a journalist, an employee of the U.S. federal government with a ".GOV" domain name, or a resident of nearly any developing country or transition economy.

If you usually get free papers at work/university but do not at home, you can either connect to your work VPN or proxy (if any) or elect to have a link to the paper emailed to your work email address below. The email address must be connected to a subscribing college, university, or other subscribing institution. Gmail and other free email addresses will not have access.


The NBER Bulletin on Aging and Health provides summaries of publications like this.  You can sign up to receive the NBER Bulletin on Aging and Health by email.

Machine-readable bibliographic record - MARC, RIS, BibTeX

Document Object Identifier (DOI): 10.3386/w24095

Forthcoming: Cost Sharing in Insurance Coverage for Precision Medicine, Mark V. Pauly. in Economic Dimensions of Personalized and Precision Medicine, Berndt, Goldman, and Rowe. 2018

Users who downloaded this paper also downloaded* these:
Bradley, Neumark, and Saxe Walker w24100 The Effect of Primary Care Visits on Health Care Utilization: Findings from a Randomized Controlled Trial
Chandra, Garthwaite, and Stern w24026 Characterizing the Drug Development Pipeline for Precision Medicines
Einav and Finkelstein w24055 Moral Hazard in Health Insurance: What We Know and How We Know It
Gabaix w24096 Behavioral Inattention
Fadlon and Nielsen w24042 Family Health Behaviors
NBER Videos

National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email:

Contact Us